Clinigen Clinical Supplies Management Belgium
0668.717.010 · rovalta.com · 28/09/2026
NORMAL SITUATION
Clinigen Clinical Supplies Management Belgium
Company — Normal situation.
Financial year 2025 · Closed on 30/06/2025
Net result-2,9 M €+3,1 %over 1 year
Equity-10,4 M €-38,1 %over 1 year
Overview
Identity
Source · BCE/KBOClinigen Clinical Supplies Management Belgium is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0668.717.010
- Legal form
- Private limited company
- Contributed capital
- 4 852 550,00 €
- Latest accounts
- 30/06/2025
Signals
Good liquidity
Financials
Source · NBB, 8 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | – | -10 k € | – | -10,1 k € | +11.8% | -11,5 k € | |||
| EBITDA | 0 € | +100% | -11 k € | -1134% | -888 € | +91.9% | -11 k € | +4.3% | -11,5 k € |
| Operating result | -2,6 M € | +0.4% | -2,6 M € | -0.4% | -2,6 M € | +0.4% | -2,6 M € | -22910% | -11,5 k € |
| Net result | -2,9 M € | +3.1% | -2,9 M € | -1.8% | -2,9 M € | +0.3% | -2,9 M € | -920% | -284,9 k € |
| Balance sheet | |||||||||
| Equity | -10,4 M € | -38.1% | -7,5 M € | -64.8% | -4,5 M € | -175% | -1,7 M € | -140% | 4,2 M € |
| Total assets | 2,3 M € | -52.1% | 4,9 M € | -35.1% | 7,5 M € | -25.7% | 10,1 M € | -36.3% | 15,9 M € |
| Cash | – | 34,2 k € | -10.8% | 38,4 k € | +13795% | 276 € | -92.2% | 3,6 k € | |
| Debts | 12,7 M € | +2.5% | 12,4 M € | +2.5% | 12,1 M € | +2.4% | 11,8 M € | +0.4% | 11,7 M € |
Board of directors
Source · NBB, accounts to 30/06/20254 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Veronique Beautrix | Director27/12/2024 → 27/12/2030 | ||
Gunter Van Hoof | Director08/05/2023 → 30/06/2028Mandateended | ||
Isabelle Bertaggia | Director08/05/2023 → 30/06/2028Mandateended | ||
Richard Paling | Directorsince 28/10/2019Mandateended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Ruediger Weber | Managing director07/02/2019 → 12/11/2024 | ||
Scott Houlton | Managing director09/01/2017 → 28/10/2019Directorsince 04/01/2017 | ||
PHILIPPE VANDERHOFSTADT | Managing directorsince 04/01/2017 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/01/2026 | 03/02/2025 | 20/11/2023 | 08/12/2022 | 07/12/2021 | 10/11/2020 |
| General meeting | 26/12/2025 | 27/12/2024 | 13/11/2023 | 14/11/2022 | 08/11/2021 | 09/11/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/06/2025 | 26/12/2025 | 29/01/2026 | French | |
| Abridged model | 30/06/2024 | 27/12/2024 | 03/02/2025 | French | |
| Abridged model | 30/06/2023 | 13/11/2023 | 20/11/2023 | French | |
| Abridged model | 30/06/2022 | 14/11/2022 | 08/12/2022 | French | |
| Abridged model | 30/06/2021 | 08/11/2021 | 07/12/2021 | French | |
| Abridged model | 30/06/2020 | 09/11/2020 | 10/11/2020 | French | |
| Micro model | 30/06/2019 | 09/12/2019 | 30/12/2019 | French | |
| Micro model | 31/12/2017 | 04/06/2018 | 13/06/2018 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20254 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Veronique Beautrix | Director27/12/2024 → 27/12/2030 | ||
Gunter Van Hoof | Director08/05/2023 → 30/06/2028Mandateended | ||
Isabelle Bertaggia | Director08/05/2023 → 30/06/2028Mandateended | ||
Richard Paling | Directorsince 28/10/2019Mandateended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Ruediger Weber | Managing director07/02/2019 → 12/11/2024 | ||
Scott Houlton | Managing director09/01/2017 → 28/10/2019Directorsince 04/01/2017 | ||
PHILIPPE VANDERHOFSTADT | Managing directorsince 04/01/2017 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring09/03/2026Fusion par absorption
- Restructuring30/12/2025Dépôt projet commun de fusion conformément aux articles 12:24 juncto
- Mandates17/10/2025Démission d'un administrateur
- Mandates14/03/2025Nomination Commissaire
- Mandates14/03/2025Nomination d'un administrateur
- Mandates23/08/2023DEMISSIONS, NOMINATIONS
- Mandates19/05/2023DEMISSIONS, NOMINATIONS
- Restructuring05/01/2021CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Name
Registered office
Annual accounts
Filings7 filings
Mandates
Veronique Beautrix
Isabelle Bertaggia
Gunter Van Hoof
Richard Paling
Ruediger Weber
Scott Houlton
PHILIPPE VANDERHOFSTADT
20172018201920202021202220232024202520262027202820292030
Clinigen Clinical Supplies Management Belgium
Rue Granbonpré 11, 1435 Mont-Saint-Guibert
Director
Director
Director
Director
Managing director
Managing director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue Granbonpré 11, 1435 Mont-Saint-Guibert | accounts 2022 → 2025 | Accounts 2025 · 2026-00018751 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Clinigen Clinical Supplies Management Belgium | accounts 2022 → 2025 | Accounts 2025 · 2026-00018751 |
Events
- 2025Annual accounts 2025-2,9 M €↑
- 2024Annual accounts 2024-2,9 M €↓
- 2023Annual accounts 2023-2,9 M €↑
- 2022Annual accounts 2022-2,9 M €↓
- 2020Annual accounts 2020-284,9 k €↑
- 2019Annual accounts 2019-474,2 k €↓
- 2017Annual accounts 201772,2 k €